Report Categories
View AllRecent Articles
View All
Is Fate Therapeutics Fate Stock In A Selling Zone Fate Q4 2025 Earnings Fate Therapeutics Inc. Tops Eps Estimates Reports No Revenue 20260413 1
Is Tempus Ai Tem Stock Testing Resistance Price At 47.76 Up 0.78 20260406
What Valuation Model Applies To Xtl Xtlb Stock Price At 2.40 Down 1.84 20260408
Tecogen Inc Q1 2026 Earnings Earnings Beat Estimates Despite Narrower Loss
Customers Bancorp Inc CUBB Q1 2026 Earnings Modest EPS Beat Highlights Steady Performance
DouYu Q4 2025 Earnings EPS Surges Past Estimates Despite Revenue Disclosures
SDHC Q1 2026 Earnings BottomLine Beat Defies Soft Housing Headwinds
CNX Resources Q1 2026 Earnings Strong EPS Beat Despite Stock Decline